drugset / Trial / NCT02755428

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

NCT02755428 ↗

NaSingle-groupOpen-labelOther

Summary

This project intends to transplant human embryonic stem cells derived retinal pigment epitheliums into subretinal space of patients to treat dry age-related macular degeneration(dry-AMD).And we will assess the safety and efficacy of RPE transplants to treat dry AMD.

Timeline

Start
2018-01
Primary completion
2019-01
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject retinal pigment epithelium transplantation Cell therapy — Other